Newly Diagnosed

Learn More Today


We are a click


or a call away



Health Care Providers

The Sturge-Weber Foundation is soliciting applications for financial support of research related to Sturge-Weber syndrome. Grant applications from qualified investigators at any career stage for innovative research programs conducted at universities and medical schools will be considered. The current cycle of the Foundation’s grant program is funded at the level of $30,000 per year and grant awards of up to $30,000 are anticipated for projects lasting no more than two years. Indirect costs will not be funded. Applications should be received by the Foundation by November 15, 2013 with project start dates expected to be approximately March 1, 2014. Applications will be reviewed and action recommended by the Medical Advisory Board Executive Committee and additional external reviewers as needed. Recommended grant awards must be approved by the Foundation’s Board of Directors.


Applications should include the following:

1.Brief abstract in non-technical language that the Foundation may disclose publicly if the application is successful.

2.Brief summary of the factors that have motivated the principal investigator to pursue Sturge-Weber syndrome research.

3.Specific aims.


5.Preliminary studies, if any.

6.Approach and methodology.

7.Cited literature.

8.Principal investigator’s biosketch including current and pending support.

9.Facilities and resources available at the sponsoring institution to support the project.

10.If vertebrate animals are to be used, documentation of IACUC approval.

11.If human subjects are to be involved, identification of potential risks. Documentation of IRB approval will be required prior to funding.

12.Budget and justification.

13.Documentation of endorsement by an appropriate official from the institution.


Items 3–6 above should be limited to a total of four pages in 11 point font or larger; one-half inch margins on 8.5 x 11 inch paper format; standard single spacing.


Applications should be submitted electronically as PDF files to:

Charles Swindell, PhD

Chief Scientific Officer

This email address is being protected from spambots. You need JavaScript enabled to view it.